This PDF is the current document as it appeared on Public Inspection on 01/22/2014 at 08:45 am.
Food and Drug Administration, HHS.Start Printed Page 3822
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, Postmarketing Studies Status Reports, and Forms FDA 356h and 2567” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
On November 13, 2013, the Agency submitted a proposed collection of information entitled “Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, Postmarketing Studies Status Reports, and Forms FDA 356h and 2567” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0338. The approval expires on January 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.Start Signature
Dated: January 15, 2014.
Assistant Commissioner for Policy.
[FR Doc. 2014-01233 Filed 1-22-14; 8:45 am]
BILLING CODE 4160-01-P